Filing Details

Accession Number:
0001354488-17-000512
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-17 16:05:07
Reporting Period:
2017-05-15
Filing Date:
2017-05-17
Accepted Time:
2017-05-17 16:05:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489798 Janet Dillione C/o Cormedix Inc.
1430 U.s. Highway 206, Suite 200
Bedminster NJ 07921
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-15 21,231 $0.48 39,969 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock Acquisiton 2017-05-15 15,306 $0.00 15,306 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,306 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy Common Stock) $2.24 2027-02-21 40,000 40,000 Direct
Common Stock Restricted Stock Units $0.00 15,357 15,357 Direct
Common Stock Phantom Stock $0.00 3,472 3,472 Direct
Common Stock Phantom Stock $0.00 4,143 4,143 Direct
Common Stock Stock Option (Right to Buy Common Stock) $3.03 2025-08-11 50,000 50,000 Direct
Common Stock Phantom Stock $0.00 1,415 1,415 Direct
Common Stock Stock Option (Right to Buy Common Stock) $1.91 2026-02-21 95,000 95,000 Direct
Common Stock Phantom Stock $0.00 3,831 3,831 Direct
Common Stock Phantom Stock $0.00 2,767 2,767 Direct
Common Stock Phantom Stock $0.00 4,335 4,335 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-02-21 40,000 40,000 Direct
15,357 15,357 Direct
3,472 3,472 Direct
4,143 4,143 Direct
2025-08-11 50,000 50,000 Direct
1,415 1,415 Direct
2026-02-21 95,000 95,000 Direct
3,831 3,831 Direct
2,767 2,767 Direct
4,335 4,335 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.473 to $0.475. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  3. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  4. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  5. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.